Today’s Solutions: October 16, 2026

For too long, migraines have been a black spot in medical research. Now sufferers of the condition can have hope after a new antibody treatment developed specifically for migraine prevention has just completed Phase III human clinical trials with remarkably positive results. In the study, respondents reported a 50 percent reduction in monthly migraine days. 

Solutions News Source Print this article
More of Today's Solutions

What to leave alone in your garden this October to help overwintering bees

BY THE OPTIMIST DAILY EDITORIAL TEAM Every fall there's a pull to tidy things up. Cut back the perennials, rake the leaves, clear the ...

Read More

What sets Japanese sweet potatoes apart, nutritionally speaking

BY THE OPTIMIST DAILY EDITORIAL TEAM If you've bought a Japanese sweet potato, cut into it expecting orange, and found creamy white instead, you've ...

Read More

A guide to the 2024 solar eclipse

When the skies over Mexico and North America darken on April 8, all eyes will be drawn upward to behold a celestial phenomenon that ...

Read More

Elk win the right of way in Colorado thanks to a rancher’s bold conservation ...

BY THE OPTIMIST DAILY EDITORIAL TEAM If you’re an elk trekking through Park County, Colorado, winter just got a little bit smoother. Thanks to ...

Read More